ATE369868T1 - Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion - Google Patents

Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion

Info

Publication number
ATE369868T1
ATE369868T1 AT01952931T AT01952931T ATE369868T1 AT E369868 T1 ATE369868 T1 AT E369868T1 AT 01952931 T AT01952931 T AT 01952931T AT 01952931 T AT01952931 T AT 01952931T AT E369868 T1 ATE369868 T1 AT E369868T1
Authority
AT
Austria
Prior art keywords
female sexual
relates
present
disorders
compositions
Prior art date
Application number
AT01952931T
Other languages
English (en)
Inventor
Martin Crosby
Robert Bennett
Original Assignee
Qualilife Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qualilife Pharmaceuticals Inc filed Critical Qualilife Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE369868T1 publication Critical patent/ATE369868T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT01952931T 2000-06-27 2001-06-27 Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion ATE369868T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21447200P 2000-06-27 2000-06-27

Publications (1)

Publication Number Publication Date
ATE369868T1 true ATE369868T1 (de) 2007-09-15

Family

ID=22799196

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01952931T ATE369868T1 (de) 2000-06-27 2001-06-27 Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion

Country Status (8)

Country Link
US (3) US6737084B2 (de)
EP (1) EP1328281B1 (de)
AT (1) ATE369868T1 (de)
AU (1) AU2001273636A1 (de)
CA (1) CA2417552C (de)
DE (1) DE60130007T2 (de)
ES (1) ES2291333T3 (de)
WO (1) WO2002000240A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE369868T1 (de) 2000-06-27 2007-09-15 Qualilife Pharmaceuticals Inc Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion
US20060254597A1 (en) * 2000-12-14 2006-11-16 40J's Llc Method of treatment of atrophic vaginitis by topical clitoral menthol or a related cooling compound
GB0129987D0 (en) * 2001-12-14 2002-02-06 Zylepsis Ltd Skin compositions
GB0208704D0 (en) * 2002-04-16 2002-05-29 Futura Medical Dev Ltd Condom
EP2368445A1 (de) * 2002-06-18 2011-09-28 Martek Biosciences Corporation Stabile Emulsionen von Ölen in wässrigen Lösungen und Verfahren zu ihrer Herstellung
ITMI20030661A1 (it) 2003-04-04 2004-10-05 Indena Spa Processo per la preparazione della ferutinina da piante del genere ferula
ITMI20031428A1 (it) * 2003-07-11 2005-01-12 Indena Spa Combinazioni di agenti vasoattivi e loro uso per il trattamento di disfunzioni sessuali
EP1699436A2 (de) * 2003-12-12 2006-09-13 Myogen, Inc. Enoximon-formulierungen und ihre verwendung bei der behandlung von herzhypertrophy und herzinsuffizienz
US20050187507A1 (en) * 2004-01-08 2005-08-25 Reed Andre' L. Method and apparatus for removal of menses, reduction of menses interference during coitus, and enhancement of sexual pleasure
US20060025463A1 (en) * 2004-03-22 2006-02-02 Michael Bristow Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases
EP1737447A1 (de) * 2004-03-22 2007-01-03 Myogen, Inc. (r)-enoximonsulfoxid und seine verwendung in der behandlung von pde-iii-vermittelten erkrankungen
US6949067B1 (en) * 2004-05-11 2005-09-27 Dann Jeffrey A Device and method for enhancing female sexual stimulation
CA2572179A1 (en) * 2004-06-23 2006-01-19 Myogen, Inc. Enoximone formulations and their use in the treatment of pde-iii mediated diseases
US20100233295A1 (en) * 2005-03-02 2010-09-16 Vibha Gupta Aqueous moisturizers and lubricants and uses thereof
US8703198B2 (en) * 2005-03-02 2014-04-22 Aquatrove Biosciences Water-based personal moisturizers and lubricants, in particular vaginal lubricants, and uses thereof
GB0504547D0 (en) * 2005-03-04 2005-04-13 Delsol Products Ltd Personal lubricant
US20090041743A1 (en) * 2007-08-10 2009-02-12 Ma Te Lun Sperm-blocking agent composition with contraceptive effect
US20090054498A1 (en) * 2007-08-21 2009-02-26 Nawaz Ahmad Anhydrous Compositions Useful for Attaining Enhanced Sexual Wellness
US20090054497A1 (en) * 2007-08-21 2009-02-26 Nawaz Ahmad Methods for attaining enhanced sexual wellness using anhydrous compositions
US20090197892A1 (en) * 2007-08-21 2009-08-06 Nawaz Ahmad Anhydrous compositions useful for attaining enhanced sexual wellness
WO2011005438A2 (en) * 2009-06-22 2011-01-13 Donaldson Company, Inc. Filter element support assembly, quick installation system, and methods
US20110002966A1 (en) * 2009-07-01 2011-01-06 Alex Lovett Vaginal Suppository System and Method
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US20130040923A1 (en) 2011-05-13 2013-02-14 Trimel Pharmaceuticals Corporation Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
EP2706985B1 (de) 2011-05-13 2020-07-22 Acerus Biopharma Inc. Intranasale niedriger dosierte testosterongelformulierungen und ihre verwendung zur behandlung von anorgasmie oder hypoaktivem sexuellem verlangen
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
WO2014204853A1 (en) * 2013-06-19 2014-12-24 Access Business Group International Llc Plant-based inhibitors of ketohexokinase for the support of weight management
WO2015027201A1 (en) * 2013-08-22 2015-02-26 Baxco Pharmaceutical, Inc. Methods and compositions for enhancing female sexual wellness
CN103651359B (zh) * 2013-11-26 2015-09-23 武汉天惠生物工程有限公司 蛇床子素生物杀虫剂
US10226418B2 (en) 2014-05-12 2019-03-12 Susie Q, Ltd. Arginine-containing topical composition
CN104351181A (zh) * 2014-10-28 2015-02-18 山东中大药业有限公司 有效成分为大蒜素和蛇床子素的微囊悬浮剂
US20230041289A1 (en) * 2021-08-05 2023-02-09 Innovus Pharmaceuticals, Inc. Compositions and methods for enhancing or treating female sexual response

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5231022B2 (de) * 1972-10-06 1977-08-12
US4135514A (en) 1974-12-23 1979-01-23 Alza Corporation Osmotic releasing system for administering ophthalmic drug to eye of animal
DE2602297B1 (de) 1976-01-22 1977-01-13 Merz & Co Vaginalzaepfchen zur empfaengnisverhuetung mit einem gehalt an milchalbumin
DE2654796A1 (de) 1976-12-03 1978-06-08 Hoechst Ag Polyoxygenierte labdan-derivate
US4076854A (en) * 1977-03-03 1978-02-28 International Flavors & Fragrances Inc. Flavoring with a cyclohexadiene derivative
US4393871A (en) 1977-06-27 1983-07-19 Vli Corporation Vaginal device
US4317447A (en) 1979-07-19 1982-03-02 Ortho Pharmaceutical Corporation Drug delivery system
US4475916A (en) 1982-03-18 1984-10-09 Merck & Co., Inc. Osmotic drug delivery system
DE3479423D1 (en) 1984-02-29 1989-09-21 Covex Sa Citrate of vinpocetine, and process for its preparation
US4692441A (en) 1985-08-16 1987-09-08 Merck & Co., Inc. Chorine esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities
AU591196B2 (en) 1985-11-15 1989-11-30 Nippon Kayaku Kabushiki Kaisha Novel forskolin derivatives
US4989618A (en) 1988-02-24 1991-02-05 Vance Products Incorporated Device and method for intravaginal, barrier-type prevention of conception and infection
US5207232A (en) 1988-02-24 1993-05-04 Alfred A. Shihata Device and method for intravaginal, barrier-type prevention of conception and infection
US4858624A (en) 1988-02-24 1989-08-22 Vance Products Incorporated D/B/A/ Cook Urological Incorporated And Cook Ob/Gyn Device and method for intravaginal, barrier-type prevention of conception and infection
NO179479C (no) 1988-03-11 1996-10-16 Teikoku Seiyaku Kk Fremgangsmåte for fremstilling av et intravaginalt farmasöytisk preparat
US4873078A (en) * 1988-04-22 1989-10-10 Plough, Inc. High-gloss, high-shine lipstick
JP2628346B2 (ja) * 1988-07-01 1997-07-09 株式会社トプコン メモリカード格納装置
US5084277A (en) 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
US4999351A (en) 1989-01-11 1991-03-12 Hoechst-Roussel Pharmaceuticals, Inc. 7-aryl and heteroaryl ethers of desacetylforskolin
US5177207A (en) 1989-01-11 1993-01-05 Hoechst-Roussel Pharmaceuticals, Inc. 7-aryl and heteroaryl ethers of desacetylforskolin
US5093336A (en) 1989-07-06 1992-03-03 Hoechat-Roussel Pharmaceuticals, Inc. 6- and 7-deoxyforskolin and derivatives thereof
US5145855A (en) 1989-07-06 1992-09-08 Hoechst Roussel Pharmaceuticals, Inc. 6- and 7-deoxyforskolin and derivatives thereof
FR2650952B1 (fr) * 1989-08-17 1994-10-14 Lvmh Rech Composition cosmetique ou pharmaceutique, notamment dermatologique, contenant un extrait de coleus et procede pour sa preparation
EP0447962A1 (de) 1990-03-17 1991-09-25 Hoechst Aktiengesellschaft Labdane und Verfahren zu ihrer Herstellung
EP0650723A3 (de) 1990-03-23 1995-08-30 Nippon Kayaku Kk Neue pharmazeutische Verwendungen von Forskolin-Derivaten.
US5350864A (en) 1990-05-03 1994-09-27 The United States Of America As Represented By The Department Of Health And Human Services Aminoalkylcarbamyl derivatives of forskolin as intermediates for the synthesis of useful forskolin derivatives
US5077274A (en) * 1990-10-12 1991-12-31 International Flavors & Fragrances Inc. Bicyclo[10.2.0]tetradecan-13-one, fragrance use thereof, process for preparing same and dichlorinated intermediate used in said process
GB9111900D0 (en) * 1991-06-03 1991-07-24 Efamol Holdings Fatty acid compositions
PT100944B (pt) 1991-10-10 2000-02-29 Alza Corp Dispositivo para o fornecimento osmotico de farmacos com paredes de materiais hidrofobicos
JPH05194179A (ja) * 1992-01-21 1993-08-03 Kanebo Ltd 皮膚化粧料
US5393528A (en) 1992-05-07 1995-02-28 Staab; Robert J. Dissolvable device for contraception or delivery of medication
GB9211229D0 (en) 1992-05-27 1992-07-08 Efamol Holdings Fatty acid treatment
US5698589A (en) 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
US5310556A (en) * 1993-06-09 1994-05-10 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic composition
CN1097311A (zh) 1993-07-14 1995-01-18 杨景信 用于性卫生保健用药妇春康软膏的制作方法
US5565466A (en) 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
CN1104886A (zh) * 1994-01-06 1995-07-12 田华琴 祛斑、祛粉刺、祛皱护肤霜
US5731339A (en) 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response
JPH08333266A (ja) * 1995-06-09 1996-12-17 Masatoshi Yamada 植物の活性成分を含有する医薬およびその用途
US6036977A (en) 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
US5690947A (en) * 1996-08-30 1997-11-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Borage seed oil as an anti-irritant in compositions containing hydroxy acids or retinoids
US5958926A (en) 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
CA2305394C (en) 1997-10-28 2006-12-12 Vivus, Incorporated Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US5877216A (en) 1997-10-28 1999-03-02 Vivus, Incorporated Treatment of female sexual dysfunction
US5945117A (en) 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction
FR2777179A1 (fr) * 1998-04-09 1999-10-15 Lvmh Rech Compositions cosmetiques ou dermatologiques comprenant un vehicule a base d'un liquide hydrophobe
US6046240A (en) 1998-05-01 2000-04-04 Harvard Scientific Corporation Methods for treating female sexual dysfunction
US5891915A (en) 1998-05-01 1999-04-06 Wysor; Michael S. Method for enhancing female sexual response and an ointment therefor
US6007824A (en) 1998-07-09 1999-12-28 Duckett; Melvin J. Natural composition and method for the treatment of sexual dysfunction
WO2000016752A2 (en) * 1998-09-18 2000-03-30 Lavipharm Laboratories, Inc. Transdermal devices comprising essential oils for aromatherapy
JP2000119156A (ja) * 1998-10-14 2000-04-25 Kose Corp 皮膚外用剤
CN1237413A (zh) * 1999-05-06 1999-12-08 马宏 芦荟美容化妆品
WO2000069406A1 (en) * 1999-05-18 2000-11-23 The Procter & Gamble Company Methods of regulating the condition of mammalian keratinous tissue
ATE369868T1 (de) 2000-06-27 2007-09-15 Qualilife Pharmaceuticals Inc Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion

Also Published As

Publication number Publication date
DE60130007D1 (de) 2007-09-27
WO2002000240A3 (en) 2003-09-25
US20020034557A1 (en) 2002-03-21
EP1328281A1 (de) 2003-07-23
CA2417552C (en) 2014-05-13
US6737084B2 (en) 2004-05-18
US20110117228A1 (en) 2011-05-19
US20040202739A1 (en) 2004-10-14
US7875299B2 (en) 2011-01-25
EP1328281B1 (de) 2007-08-15
DE60130007T2 (de) 2008-04-30
US8128972B2 (en) 2012-03-06
ES2291333T3 (es) 2008-03-01
CA2417552A1 (en) 2002-01-03
WO2002000240A2 (en) 2002-01-03
AU2001273636A1 (en) 2002-01-08

Similar Documents

Publication Publication Date Title
ATE369868T1 (de) Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion
BR0013897A (pt) Uso de ácido linoleico conjugado (cla) ou de um seu derivado, composição tópica cosmética ou dermatológica, e, método de tratamento e/ou de profilaxia de celulite e de depósitos de gordura
DE69714714D1 (de) Verwendung eines extraktes mindestens einer in vitro kultivierten labiate der gattung rosmarinarus in einer zusammensetzung
EA200870393A1 (ru) Новые композиции для нарушений волос и способ получения композиций
DE60004374D1 (de) Zusammensetzung zur behandlung von infektionen bei mensch und tier
WO2006109898A8 (en) Antimicrobial composition containing natural extract, nano silver and natural essential oil
CL2004002050A1 (es) Compuestos derivados de piridinonas sustituidas; su uso en el tratamiento de afecciones causadas o exacerbadas por actividad p38 map kinasa y/o tnf no regulada, tales como inflamaciones, tumores, sida y otros.
EA200900733A1 (ru) ЗАМЕЩЁННЫЕ ПРОИЗВОДНЫЕ 2,3-ДИГИДРОИМИДАЗО[1,2-c]ХИНАЗОЛИНА, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ ГИПЕРПРОЛИФЕРАТИВНЫХ НАРУШЕНИЙ И БОЛЕЗНЕЙ, СВЯЗАННЫХ С АНГИОГЕНЕЗОМ
BRPI0512864A (pt) composições e métodos para o tratamento de condições e desordens oculares
DE502005008971D1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht
BRPI0407375A (pt) Métodos para tratar dor por meio da administração de um antagonista do fator de crescimento neural e u nsaid e composições contendo os mesmos
DE602005007188D1 (de) Zuckerlacton enthaltende zusammensetzung zur haarbehandlung
DE502005008058D1 (de) Gesättigte und ungesättigte 3-pyridyl-benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen
BR0317888A (pt) Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos
Büyükafşar et al. Effects of the Rho-kinase inhibitors, Y-27632 and fasudil, on the corpus cavernosum from diabetic mice
MXPA06013179A (es) Composicion anti-acne para el cuidado de la piel y articulo para el cuidado de la piel.
MXPA05010416A (es) Combinacion de substancias activas de aceites minerales que contienen acidos grasos (3 con extractos vegetales que contengan polifenoles y su uso.
TW200612972A (en) Essential oils for treating and/or preventing allergic disease
CN104306301A (zh) 一种婴儿用沐浴露
CN105030613A (zh) 一种抗菌缓解疲劳的天然植物精油洗脚液
CN108949393A (zh) 一种添加植物活性成分的手工皂
WO2010041908A3 (ko) 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물의 신규한 용도
EE03169B1 (et) Ravim erutusseisundite ja närvitalitlushäirete leevendamiseks või seiskamiseks
US20050100618A1 (en) Method of using a compound of menthol and L-arginine as a preparation for the topical delivery of Icariin, a herbal product produced from the Epimedium genus of the Berberidaceal family of plants, for the treatment of sexual dysfunction
PH22017000624Y1 (en) Liniment composition from sweet sop (annona squamosa) leaves

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties